Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Inventory (2020 - 2026)

Sight Sciences has reported Inventory over the past 6 years, most recently at $7.8 million for Q4 2025.

  • For Q4 2025, Inventory rose 22.8% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, up 22.8%, while the annual FY2025 figure was $7.8 million, 22.8% up from the prior year.
  • Inventory for Q4 2025 was $7.8 million at Sight Sciences, down from $8.0 million in the prior quarter.
  • Over five years, Inventory peaked at $9.2 million in Q3 2023 and troughed at $2.6 million in Q2 2021.
  • A 5-year average of $6.1 million and a median of $6.2 million in 2025 define the central range for Inventory.
  • Biggest five-year swings in Inventory: skyrocketed 91.77% in 2022 and later plummeted 34.08% in 2024.
  • Year by year, Inventory stood at $3.5 million in 2021, then soared by 75.94% to $6.1 million in 2022, then increased by 28.38% to $7.8 million in 2023, then dropped by 19.42% to $6.3 million in 2024, then rose by 22.8% to $7.8 million in 2025.
  • Business Quant data shows Inventory for SGHT at $7.8 million in Q4 2025, $8.0 million in Q3 2025, and $6.2 million in Q2 2025.